Q1 FY2023 · Quarterly report
90 pages
Read ARS Pharmaceuticals, Inc.'s results firsthand
Preview the first 2 pages of this quarterly report
Create a free account to start reading
Full documents are included with Professional
ARS Pharmaceuticals, Inc.
NNASDAQ:SPRY2.79
USD
+0.14
(+5.28%)
